141 related articles for article (PubMed ID: 1251141)
1. Testicular function after combination chemotherapy for Hodgkin's disease.
Asbjornsen G; Molne K; Klepp O; Aakvaag A
Scand J Haematol; 1976 Jan; 16(1):66-9. PubMed ID: 1251141
[TBL] [Abstract][Full Text] [Related]
2. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
[TBL] [Abstract][Full Text] [Related]
3. The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
Gerres L; Brämswig JH; Schlegel W; Jürgens H; Schellong G
Cancer; 1998 Nov; 83(10):2217-22. PubMed ID: 9827728
[TBL] [Abstract][Full Text] [Related]
4. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
Clark ST; Radford JA; Crowther D; Swindell R; Shalet SM
J Clin Oncol; 1995 Jan; 13(1):134-9. PubMed ID: 7799013
[TBL] [Abstract][Full Text] [Related]
5. [Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
Soriano Guillén L; Muñoz Calvo MT; Pozo Román J; Contra Gómez T; Buño Soto M; Argente Oliver J
An Esp Pediatr; 2000 Oct; 53(4):318-23. PubMed ID: 11083980
[TBL] [Abstract][Full Text] [Related]
6. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence.
Brämswig JH; Heimes U; Heiermann E; Schlegel W; Nieschlag E; Schellong G
Cancer; 1990 Mar; 65(6):1298-302. PubMed ID: 2106384
[TBL] [Abstract][Full Text] [Related]
7. Testicular dysfunction in Hodgkin's disease before and after treatment.
Viviani S; Ragni G; Santoro A; Perotti L; Caccamo E; Negretti E; Valagussa P; Bonadonna G
Eur J Cancer; 1991; 27(11):1389-92. PubMed ID: 1835853
[TBL] [Abstract][Full Text] [Related]
8. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM
Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817
[TBL] [Abstract][Full Text] [Related]
9. Gonadal function following ABVD therapy for Hodgkin's disease.
Kulkarni SS; Sastry PS; Saikia TK; Parikh PM; Gopal R; Advani SH
Am J Clin Oncol; 1997 Aug; 20(4):354-7. PubMed ID: 9256888
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a specific seminiferous tubular factor affecting follicle-stimulating hormone secretion in man.
Van Thiel DH; Sherins RJ; Myers GH; De Vita VT
J Clin Invest; 1972 Apr; 51(4):1009-19. PubMed ID: 4552337
[TBL] [Abstract][Full Text] [Related]
11. Male reproductive potential after MOPP therapy for Hodgkin's disease: a long-term survey.
Marmor D; Duyck F
Andrologia; 1995; 27(2):99-106. PubMed ID: 7598233
[TBL] [Abstract][Full Text] [Related]
12. Treatment with the gonadotropin-releasinghormone agonist buserelin to protect spermatogenesis against cytotoxic treatment in young men.
Krause W; Pflüger KH
Andrologia; 1989; 21(3):265-70. PubMed ID: 2476046
[TBL] [Abstract][Full Text] [Related]
13. Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease.
Kreuser ED; Xiros N; Hetzel WD; Heimpel H
J Cancer Res Clin Oncol; 1987; 113(3):260-6. PubMed ID: 3108263
[TBL] [Abstract][Full Text] [Related]
14. Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence.
Bordallo MA; Guimarães MM; Pessoa CH; Carriço MK; Dimetz T; Gazolla HM; Dobbin J; Castilho IA
J Pediatr Endocrinol Metab; 2004 Jun; 17(6):879-87. PubMed ID: 15270406
[TBL] [Abstract][Full Text] [Related]
15. Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
Bujan L; Walschaerts M; Brugnon F; Daudin M; Berthaut I; Auger J; Saias J; Szerman E; Moinard N; Rives N; Hennebicq S
Fertil Steril; 2014 Sep; 102(3):667-674.e3. PubMed ID: 25044088
[TBL] [Abstract][Full Text] [Related]
16. Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
Dhabhar BN; Malhotra H; Joseph R; Garde S; Bhasin S; Sheth A; Advani SH
Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):306-10. PubMed ID: 8328644
[TBL] [Abstract][Full Text] [Related]
17. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease.
Heikens J; Behrendt H; Adriaanse R; Berghout A
Cancer; 1996 Nov; 78(9):2020-4. PubMed ID: 8909325
[TBL] [Abstract][Full Text] [Related]
18. Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease.
Sherins RJ; Olweny CL; Ziegler JL
N Engl J Med; 1978 Jul; 299(1):12-6. PubMed ID: 661845
[TBL] [Abstract][Full Text] [Related]
19. Male infertility caused by the chemotherapy of Hodgkin's disease: MOPP versus ABVD.
Ragni G; Lombardi C; Santoro A; Bestetti O; Wyssling H
Acta Eur Fertil; 1983; 14(3):221-2. PubMed ID: 6199937
[No Abstract] [Full Text] [Related]
20. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.
van der Kaaij MA; Heutte N; Le Stang N; Raemaekers JM; Simons AH; Carde P; Noordijk EM; Fermé C; Thomas J; Eghbali H; Kluin-Nelemans HC; Henry-Amar M; ;
J Clin Oncol; 2007 Jul; 25(19):2825-32. PubMed ID: 17515571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]